,An article in JAMA about a study done by Joshua J. Fenton, MD shows that the risks of overdose and withdrawal following an opioid taper extends into two years following the taper.  This is different from the expected result that there might be short-term risks, but long term benefits would outweigh them.

Specifics of the Study

Data from the OptumLabs Data Warehouse for commercial insurance and Medicare Advantage enrollees, representing adults with a diverse mixture of ages, races, ethnicities, and geographical regions across the US who underwent opioid dose tapering from 2008 to 2017 after a 12-month baseline period of stable daily dosing of 50 morphine milligram equivalents or higher.

They identified tapers on the basis of a 15% or more dose reduction relative to the stable baseline dose during 6 overlapping 60-day periods following the end of the 12-month baseline period of stable dosing. They defined overdose or withdrawal events as emergency department visits or inpatient hospital admissions for any drug overdose, alcohol intoxication, or drug withdrawal. They defined mental health crisis events as emergency department or inpatient hospital admissions with depression or anxiety diagnosis codes in the primary diagnosis position or suicide attempt or intentional self-harm in any diagnosis position.

Results

19, 377 patients were in the study with a median age of 56.9 years, a little more than half were women, and 38.2% had commercial insurance. From 2008 to 2017, there were 30 255 tapering events. Baseline MMEs were as follows:

  • MME 50 to <90: 22.7%
  • MME 90 to <150: 23.8%
  • MME 150 to <300: 31.5%
  • MME ≥300: 22.0%

Rates of overdose/withdrawal were 3.5% during the pre-taper period versus 5.4% in the postinduction period—a 57% higher rate. For mental health crises rates were 3.0% during the pre-taper period and 4.4% in the postinduction period—a 52% higher rate. The mean opioid dose reduction during the first 60-day postinduction period was 39%; Incidence rates of overdose or withdrawal, and mental health crisis were each increased significantly in the postinduction period compared with the pretaper period.

Adjusted incidence rate ratios (IRRs) for postinduction adverse events were highest for patients in the highest baseline dose group (300 MME).  Adjusted IRRs of overdose withdrawal and overdose during the postinduction period compared with the pretaper period were greater among patients whose postinduction doses were 50%  to 114% of their baseline doses compared with patients who discontinued opioids or sustained a dose reduction of 1% to 49% of baseline. For mental health crises, there was no significant difference in adjusted IRRs by achieved dose.

Conclusion of the Study

The increased rates of overdose and mental health crisis observed during the first year after tapering persist through the end of the 24-month follow-up. No achieved tapered dose was associated with significantly reduced posttaper rates of adverse events compared with the pretaper period, and findings suggest that, for most tapering patients, elevated risks of overdose and mental health crisis may persist for up to 2 years after taper initiation.

Solution

It should become obvious that attacking pain management by withholding appropriate opioid treatment is causing more harm than good. The entire purpose of the attacks on opioids is purely a government agenda created by the DOJ and DEA to preserve their jobs.  We hold the answer on Doctorsofcourage.org and Sevenpillarstotalhealth.com.  No drug causes addiction.  By continuing the propaganda that opioids (or any drug) is the cause of addiction is only going to make the situation worse, because the REAL cause (toxicity) is being ignored.

We also know how to get to the cause of pain or musculoskeletal injury and heal the problem, removing the need for opioids.  It was because of this that Dr. Cheek was attacked by the government and prevented from treating patients. But she can explain the healing techniques to you through her ecourses.  So sign up for our newsletter so you get notices of our next ecourse offering.

Linda Cheek, MD

About the Author Linda Cheek, MD

Linda Cheek is a teacher and disenfranchised medical doctor, turned activist, author, and speaker. A victim of prosecutorial misconduct and outright law-breaking of the government agencies DEA, DHHS, and DOJ, she hopes to be a part of exonerating all doctors illegally attacked through the Controlled Substance Act. She holds the key to success, as she can offset the government propaganda that drugs cause addiction with the truth: The REAL Cause of Drug Abuse.
Get a free gift to learn how the government is breaking the law to attack your doctor: Click here to get my free gift

 

Social Media Auto Publish Powered By : XYZScripts.com